A prospective study on the prognosis of multiple sclerosis

Area of Science:

• Neurology
• Clinical Neuroscience
• Neuroimmunology

Background:

• Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system.
• Predicting the long-term prognosis of MS is crucial for patient management and treatment strategies.
• Early indicators of disease progression can significantly impact clinical decision-making.

Purpose of the Study:

• To identify early predictors of unfavorable prognosis in patients with newly diagnosed multiple sclerosis.
• To evaluate the prognostic value of clinical, functional, and paraclinical factors in MS.

Main Methods:

• Prospective follow-up of 224 patients with first-time MS diagnosis for a mean of 9.78 years.
• Assessment of disability using the Expanded Disability Status Scale (EDSS) and identification of secondary progressive MS.
• Analysis of clinical factors including disease course, functional systems involvement, and relapse patterns, alongside cerebrospinal fluid (CSF) and MRI findings.

Main Results:

• Initially progressive MS course and higher baseline EDSS scores were the strongest predictors of poor prognosis.
• Involvement of pyramidal, visual, sphincteric, and cerebellar systems predicted worse outcomes, while sensory system involvement was favorable.
• Longer first inter-attack intervals correlated with better prognosis, but early relapse frequency showed no prognostic value.
• Cerebrospinal fluid oligoclonal banding and suggestive MRI findings in early MS were associated with a higher likelihood of worse outcomes.

Conclusions:

• Early clinical presentation, including disease course and specific functional system involvement, are key prognostic indicators in multiple sclerosis.
• While early relapses may not predict long-term outcomes, initial disability and specific neurological deficits are significant.
• Cerebrospinal fluid and MRI findings in early MS can provide additional prognostic information, aiding in risk stratification.